4D Molecular Therapeutics, Inc. (FDMT)
NASDAQ: FDMT · Real-Time Price · USD
4.240
-0.070 (-1.62%)
At close: Jul 3, 2025, 1:00 PM
4.200
-0.040 (-0.94%)
After-hours: Jul 3, 2025, 4:47 PM EDT
4D Molecular Therapeutics Market Cap
4D Molecular Therapeutics has a market cap or net worth of $196.42 million as of July 3, 2025. Its market cap has decreased by -84.04% in one year.
Market Cap
196.42M
Enterprise Value
-238.17M
1-Year Change
-84.04%
Ranking
Category
Stock Price
$4.24
Market Cap Chart
Since the IPO on December 11, 2020, 4D Molecular Therapeutics's market cap has decreased from $580.38M to $196.42M, a decrease of -66.16%. That is a compound annual growth rate of -21.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 3, 2025 | 196.42M | -23.72% |
| Dec 31, 2024 | 257.49M | -70.27% |
| Dec 29, 2023 | 866.19M | 20.40% |
| Dec 30, 2022 | 719.43M | 2.03% |
| Dec 31, 2021 | 705.13M | -35.79% |
| Dec 31, 2020 | 1.10B | 89.22% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 700.84B |
| Johnson & Johnson | 375.37B |
| AbbVie | 334.34B |
| Novo Nordisk | 316.33B |
| UnitedHealth Group | 279.90B |
| Novartis AG | 242.35B |
| Abbott Laboratories | 233.90B |
| AstraZeneca | 218.65B |